Swiss medical technology company Getinge and US-based Zimmer Biomet have entered a strategic partnership to enhance offerings in the Ambulatory Surgery Centre (ASC) sector.
The collaboration will see Zimmer Biomet distributing Getinge’s Operating Room (OR) capital products, including infection control and surgical equipment, to ASC customers.
It aims to provide a comprehensive solution by combining Getinge’s portfolio with Zimmer Biomet’s implants and surgical robotics.
ASCs are specialised healthcare facilities that focus on providing same-day surgical care without overnight stays. In the US, ASCs perform over 22.5 million procedures annually.
Zimmer Biomet’s ZBX ASC Solutions provide the customers with access to Getinge’s surgical equipment, OR integration, and lighting.
The equipment will complement Zimmer Biomet’s joint replacement implants and technology.
The partnership will initially launch in the US, with plans to expand the combined ASC solutions portfolio to other regions globally.
Getinge North America president Patricia Fitch said: “For us, this partnership represents a significant advancement in our efforts to innovate and expand the boundaries of healthcare.
“We are thrilled to collaborate with Zimmer Biomet to deliver value to healthcare professionals and patients within the orthopedic ASC sector. This collaboration shows our commitment to making life-saving technology accessible to more people.”
Getinge offers intensive care, cardiovascular procedures, and sterile reprocessing products and solutions in over 135 countries, and employs around 12,000 people.
Zimmer Biomet focuses on maximising mobility and health through innovative products and integrated digital and robotic technologies.
Earlier this year, Zimmer Biomet acquired Paragon 28, a company specialising in foot and ankle orthopaedic care, for an equity value of around $1.1bn.
The acquisition involved an upfront payment of $13 per share in cash for all outstanding shares of Paragon 28.
Zimmer Biomet senior vice president, chief strategy, innovation and business development officer Jehanzeb Noor said: “Together with Getinge, we’re expanding our ability to deliver a comprehensive, turnkey solution for our ASC customers – faster and more seamlessly – from a company they know and trust.
“As orthopaedic surgeries increasingly migrate from traditional hospital settings to ASCs, the imperative to drive efficiency, enhance patient safety, and improve clinical outcomes has never been greater.
“By aligning with Getinge, we’re accelerating our ability to support surgeons in advancing these priorities, while shaping the future of orthopaedic care.”
